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Pb(II) Induces Scramblase 
Activation and Ceramide-Domain 
Generation in Red Blood Cells
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The mechanisms of Pb(II) toxicity have been studied in human red blood cells using confocal 
microscopy, immunolabeling, fluorescence-activated cell sorting and atomic force microscopy. The 
process follows a sequence of events, starting with calcium entry, followed by potassium release, 
morphological change, generation of ceramide, lipid flip-flop and finally cell lysis. Clotrimazole blocks 
potassium channels and the whole process is inhibited. Immunolabeling reveals the generation 
of ceramide-enriched domains linked to a cell morphological change, while the use of a neutral 
sphingomyelinase inhibitor greatly delays the process after the morphological change, and lipid flip-flop 
is significantly reduced. These facts point to three major checkpoints in the process: first the upstream 
exchange of calcium and potassium, then ceramide domain formation, and finally the downstream 
scramblase activation necessary for cell lysis. In addition, partial non-cytotoxic cholesterol depletion 
of red blood cells accelerates the process as the morphological change occurs faster. Cholesterol could 
have a role in modulating the properties of the ceramide-enriched domains. This work is relevant in the 
context of cell death, heavy metal toxicity and sphingolipid signaling.
Lead (Pb2+) is one of the most abundant heavy metals on earth. It has been widely used throughout human his-
tory, posing a serious health problem to susceptible populations. This metal causes a broad range of biochemical, 
physiological and behavioural dysfunctions. Pb2+ exposure may affect the central and peripheral nervous system, 
the hematopoietic and cardiovascular systems, kidney, liver and the reproductive system via physiological, bio-
chemical and behavioural changes1,2. In human blood about 95% lead is accumulated in red blood cells (RBC, 
erythrocytes)1 suggesting that they could be an important target of lead toxicity in the cardiovascular system3. In 
erythrocytes lead could suppress hemoglobin synthesis4, induce oxidative stress5, inhibit superoxide dismutase, 
and lower intracellular glutathione6. Lead is also known to induce shape change in erythrocytes from normal 
biconcave erythrocyte to spiked echinocyte and even achantocyte7.
Lead has been associated with the induction of apoptosis8. In studies performed on lead-exposed mammal 
erythrocytes it was found that apoptosis presumably contributes to a decrease in the life-span of erythrocytes 
and the development of anaemia in cases of lead poisoning7,9,10. Some experiments have disclosed that injured 
erythrocytes expose phosphatidylserine (PS) at their surface11. Because macrophages are equipped with receptors 
specific for phosphatidylserine12,13, erythrocytes exposing phosphatidylserine (PS) at their surface will be rapidly 
recognized, engulfed, and degraded14 thus rapidly eliminated from circulating blood.
It has been reported that micromolar or even submicromolar Pb2+ concentrations cause lipid scrambling and 
exposure of PS to the outer membrane leaflet in erythrocytes via a scramblase action, as well as calcium entry 
in proteoliposomes15. However, the cellular mechanism of the process is not yet fully understood and previous 
reports from our laboratory show that the biophysical properties of RBC membranes are also altered by the effect 
of lead16. A role of flip-flop inducing lipids, such as long-chain ceramides17,18, has also been considered for the 
PS exposure mechanism. Ceramides are of particular interest for their bioactive pro-apoptotic signalling role19,20 
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and their marked effects on membrane biophysical properties with a tendency to form highly-packed segre-
gated domains21, but their role in eryptosis has not been fully characterized yet9,22,23. However, ceramide-enriched 
domains have been already reported for erythrocytes under a hot-cold hemolytic process24. The fact that eryth-
rocyte membranes have a large amount of cholesterol, circa 45 mol%25, should also be taken into consideration, 
as it could interfere with ceramide-enriched domains26. The generation of non-purely ceramidic gel domains 
under saturating conditions is also possible and gel phases containing both ceramide and cholesterol can appear 
if both lipids are saturating the membrane27,28 which could be the case for RBC membranes under Pb2+ stress. A 
recent study from our laboratory demonstrated that RBC lipid extracts in the presence of high concentrations of 
ceramide exhibit lamellar gel domains enriched in both cholesterol and ceramide29.
In this work we provide insights about the lead-induced eryptotic mechanism. A noticeable rise in intracellu-
lar calcium via scramblase is initially detected (linked to K+ depletion30, as tested with clotrimazole inhibitor7,31), 
followed by the generation of ceramide-enriched domains in the RBC membrane and a morphological change to 
achantocytes over time. This is followed by PS exposure in the outer membrane leaflet. In the next stage sphero-
cytes are formed. Finally, when a critical amount of ceramide is reached, cell lysis occurs. Upon partial cholesterol 
depletion, the morphological change process became accelerated, suggesting a direct relationship between cho-
lesterol/ceramide-enriched domains in the membrane and the change in morphology, which in turn could govern 
the kinetics of the eryptotic process.
Results
Lipid scrambling in living cells. To measure the outward movement of lipids, RBC were first incu-
bated with fluorescent lipid probe C6-NBD-PS (1-oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hex-
anoyl]-sn-glycero-3-phosphoserine). To ensure that at the start of the floppase activity all the probe was located 
in the inner leaflet, cells were back-exchanged with BSA. Flopping of NBD lipid was then measured by continuous 
BSA extraction as described under Materials and Methods. Our results show that exposure to Pb2+, in nanomo-
lar concentrations, significantly increased the translocation of PS, in a dose-dependent manner (Fig. 1A). To 
test whether cell membrane scrambling was paralleled by loss of cell membrane integrity, release of hemoglobin 
was determined. Only a negligible fraction of erythrocytes was lysed in the presence of the Pb2+ concentrations 
used in this experiment, i.e. after 1 h exposure of erythrocytes to 10 nM Pb2+ less than 2% hemoglobin had been 
released.
Because a calcium-dependent pathway is considered to be a major mechanism for PS exposure in erythro-
cytes11, additional experiments were performed to elucidate whether intracellular calcium could be increased in 
erythrocytes after exposure to Pb2+. To this end, Fura2-AM (acetoxymetyl) fluorescence was used to measure 
changes in intracellular Ca2+ concentration following incubation of erythrocytes in the absence or presence of 
Pb2+. Intracellular calcium increased by Pb2+ treatment in a dose-dependent way (Fig. 1B). Pb2+ also increased 
Ca2+ entrance rates (Fig. 1C). Increased intracellular calcium levels can activate scramblase, which in turn causes 
PS exposure32. These results are in good agreement with those by Kempe, et al.7 and Shin, et al.33.
The involvement of a scramblase activity in PS translocation was demonstrated by transfection of a scram-
blase gene into Chinese hamster ovary (CHO) cells. CHO-K1 cells were chosen as they lack endogenous scram-
blase (protein scramblase 1, PLSCR1)34. After plasmid transfection and 24 h recovery the cells were treated with 
Pb2+. Cells were then fixed and stained. At the onset of apoptosis, PS is translocated from the cytoplasmic face 
of the plasma membrane to the cell surface. Annexin V has a strong affinity for PS and is therefore used as a 
probe for detecting early events in apoptosis. Pb2+ -stimulated phosphatidylserine exposure in CHO cells was 
observed using confocal microscopy (Fig. 2). Addition of Pb2+ increased annexin-binding to the cells in a dose 
dependent manner (Fig. 2). This result was quantified by fluorescence-activated cell sorting (FACS) analysis 
(Fig. 1E). As illustrated in Table 1, the results show an increase in annexin binding to transfected cells, but not 
to non-transfected cells. To confirm the involvement of calcium in scramblase activation, intracellular Ca2+ was 
measured as described under Materials & Methods. The results show an increase in intracellular Ca2+ concentra-
tion of transfected CHO cells (Fig. 1D) and in RBC (Fig. 1B), which also happens at higher Pb2+ concentrations 
in a dose-dependent way (Fig. 1F).
Morphological changes in RBC. Atomic Force Microscopy (AFM) imaging of RBC was achieved under 
conditions that provided consistent information, without the risk of dragging the cells along with the cantilever 
tip. Figure 3 shows the time-course of 10 µM Pb2+ effects on RBC morphology. The characteristic biconcave 
shape is lost in the first minutes, and the cells become almost flat (Fig. 3B). Spikes appear and increase in number 
in the next ~40 min (echynocytes) (Fig. 3C,D). Then after ~1 h the cells become spherical, and the spikes are 
lost (spherocytes) (Fig. 3E). At the latter stage cells begin to lyse, and their number under the AFM decreases 
gradually, as spherocytes are prone to hemolysis35. The data in Table 2 show that after 1 h Pb2+ treatment the 
diameter of the RBC decreases by about 20% while the maximum thickness increases by ~87%, as expected from 
a discoidal-to-spheroidal shape change.
Clotrimazole (CLT) is an inhibitor of Ca2+ -sensitive K+ -channels that has been proposed as an antiapoptotic 
agent36,37. Clotrimazole, which inhibits lead-induced phosphatidylserine flip-flop (Fig. 1E) also hinders the Pb2+ 
-promoted changes in RBC morphology. CLT-treated cells retain their biconcave form even after overnight treat-
ment with 10 µM Pb2+ (Fig. 3F,G). Cell diameter and maximum thickness are constant for CLT-treated RBC after 
20 min 10 µM Pb2+ incubation (Table 2), without any statistically significant difference in diameter (p = 0.26) or 
thickness at the rim (‘maximum thickness’) (p = 0.86). The fact that clotrimazole inhibited RBC shape change 
suggests that the latter is dependent on K+ exit.
AFM morphological changes could be confirmed for a large population of cells using flow cytometric meas-
urements of RBC shape38. The results in Fig. 4 indicate for control RBC the bimodal distribution of scattered 
light typical of the discoidal shape. Treatment with 10 µM Pb2+ gave rise gradually to a more uniform scattering 
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distribution (Fig. 4A,C), associated to sphericity38. In the presence of CLT the discoidal-spherical transition was 
not detected (Fig. 4C). The different morphologies detected during the Pb2+ incubation process have been quan-
tified and presented in Fig. 5.
Ceramide formation and cell lysis. The mechanism of lead-dependent cell lysis was explored next. In a 
previous study we had noted the role of ceramide-enriched domains in RBC lysis24. We had also observed that 
mechanical stress elicited a neutral sphingomyelinase activity in erythrocytes39. We reasoned that Pb2+ -induced 
morphological changes could perhaps induce a sphingomyelinase (SMase) activity in the cell membrane. In fact, 
a Pb2+ - induced SM-ase activity was found (Fig. 6A) very similar to the one described by López, et al.39 under 
mechanical stress conditions. As in the previous case, SMase activity was maximum in the first 6–8 min after 
the stress onset. SMase activity was confirmed by quantitative mass spectrometry of RBC lipids, measuring the 
amounts of SM and Cer before and after 20 min treatment with Pb(II). In that period of time SM in RBC mem-
branes slightly decreased from 4.84 ± 0.29 mol% to 4.47 ± 0.25 mol%, while ceramide significantly increased from 
0.83 ± 0.06 mol% to 1.02 ± 0.07 mol% (p < 0.01) (average ± S.E.M., n = 9).
It has been observed in many systems, including RBC lipids24,29, that Cer can give rise to rigid domains in the 
RBC membranes. In order to confirm that this was the case with our samples, RBC were incubated overnight with 
Pb(II) and the corresponding lipid extracts dispersed in buffer and analysed by differential scanning calorimetry. 
Figure 1. Effect of Pb2+ ions on cells. (A) Outward movement of fluorescent lipid analogue C6-NBD-PS in 
human RBC as a function of Pb2+ concentration. (B) Pb2+ - induced increase in intracellular Ca2+ concentration 
in human RBC and (C) Pb2+ -induced Ca2+ entrance rate in human RBC. (D) Pb2+ -induced increase in 
intracellular Ca2+ concentration of CHO cells. Intracellular free calcium was measured with Fura-2AM. Gray 
columns, scramblase-transfected cells; solid black columns, mock-transfected cells. (E) Flow cytometric analysis 
of CHO cell staining with annexin V-FITC, the inhibition of Pb2+ -induced phosphatidylserine exposure 
by channel inhibitor clotrimazole (CLT) can be quantified. (F) Pb2+ -induced increase in intracellular Ca2+ 
concentration of RBC cells for higher Pb2+ concentrations than in B. Intracellular free calcium was measured 
with Fura-2AM. Cells were incubated with Pb2+ for 1 h prior to measurements. Intracellular free calcium was 
measured with Fura-2AM. Mean values of three experiments ± S.D.
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Endotherms centred at ≈20 and 65 °C, are seen in lipid extracts from Pb(II)-treated, but not from control RBC 
(Supplementary Fig. 1). This kind of endotherms has been found in other instances of Cer formation in RBC24. 
Overnight treatment was carried out in order to facilitate the calorimetric observation of Cer. Note that the 
amount of Cer in overnight-treated cells will be higher than that present after the treatments described in Fig. 6.
The time-course of ceramide formation in the RBC membranes was estimated by labelling the cells with an 
anti-ceramide antibody and sorting the cells by FACS (Fig. 6B). Control and clotrimazole-treated cells gave no 
Figure 2. Lead-induced phosphatidylserine translocation in scramblase-transfected CHO cells. Fluorescence 
imaging of annexin V staining (green) in CHO cells. Annexin V staining was used to detect translocation of 
phosphatidylserine (PS) from the internal to the external surface of the cell membrane. Control (A), 10 nM Pb2+ 
(B), and 10 μM Pb2+ (C).
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Fluorescence intensity (a.u.)
CHO-pcDNA3.1 + 10 nM Pb2+ 2.2 ± 0.20
CHO-pcDNA3.1 + 10 µM Pb2+ 2.2 ± 0.87
CHO-Scr (Control,no Pb2+) 2.9 ± 0.54
CHO-Scr + 10 nM Pb2+ 21.4 ± 1.13
CHO-Scr + 10 µM Pb2+ 59.5 ± 1.77
Table 1. Flow cytometric analysis of CHO cell staining with annexin V-FITC. Scr-transfected and mock-
transfected cells were grown in the presence or absence of lead, treated with annexin V-FITC, and then analyzed 
by FACS. Mean values ± S.D. (n = 3).
Figure 3. AFM monitorization of 10 µM Pb2+ effect on RBC. Exposure times: 0 min (A), 6 min (B), 30 min (C), 
45 min (D), 60 min (E). Lead (II) effect on CLT-treated RBC, 20 min (F) and 15 h (G).
www.nature.com/scientificreports/
6Scientific RePoRtS |  (2018) 8:7456  | DOI:10.1038/s41598-018-25905-8
ceramide signal, while those treated with 10 µM Pb2+ indicated a maximum of ceramide contents at 20 min. 
Cells treated with the neutral SMase inhibitor GW4869 showed much decreased ceramide contents. With 
respect to cell shapes, flow cytometry confirms that, in the presence and absence of the SMase inhibitor, Pb2+ 
Pb2+ Time Pre-treatment Diameter (µm) Maximum Thickness (µm) Morphology
0 None 9.19 ± 0.65 1.44 ± 0.12 Doughnut
20 min None 8.40 ± 0.46 1.10 ± 0.11 Flat/Spiked
1 h None 7.15 ± 0.64 2.74 ± 0.28 Spherical
0 Clotrimazole 9.32 ± 0.46 1.44 ± 0.09 Doughnut
20 min Clotrimazole 9.35 ± 0.45 1.41 ± 0.07 Doughnut
15 h Clotrimazole 8.67 ± 0.21 1.21 ± 0.12 Doughnut/Flat
0 βMCD 8.74 ± 0.51 2.12 ± 0.16 Doughnut
40 min βMCD 6.94 ± 0.44 3.05 ± 0.45 Spherical
Table 2. Morphological changes induced by Pb2+ on RBC. Overview of the AFM data. Mean values ± S.D. 
(n = 50–200 cells, through 3 different experiments).
Figure 4. Monitorization of Pb(II) effect on RBC by FACS and the effect of inhibitors. RBC + Pb2+ (A), 
GW4869-treated RBC + Pb2+ (B) and comparison of control RBC (blue), +Pb2+ (black), GW4869-
treated + Pb2+ (red) and CLT-treated + Pb2+ (green) after 60 min Pb2+ incubation (C).
www.nature.com/scientificreports/
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has identical effects on RBC shapes at least in the first 30 min (Fig. 4A,B). However, AFM images of Pb2+ - and 
GW4869-treated RBC overnight are equivalent to those found 45–60 min after Pb2+ addition in the absence of 
GW4869 (Fig. 3D,E and Fig. 6C,D) which reveals that in the presence of the inhibitor no cell lysis occurs. This 
suggests that SMase activity and ceramide formation are directly related to cell lysis. The involvement of SMase in 
the process was further tested using glutathione (GSH, 5 mM) as the SMase inhibitor40. Cell lysis was quantified 
for the three inhibitors (CLT, GSH and GW4869), and all three caused a reduction in cell lysis, their inhibitory 
efficiency decreasing in the order GSH > CLT > GW4869 (Table 3).
Figure 5. Quantitation of morphologies of RBC during 1 h Pb2+ 10 µM incubation process. (n = 300–450 cells).
Figure 6. Quantitation of sphingomyelin (A) and ceramide (B) over time during Pb(II) incubation. Average of 
three measurements ± S.E.M. (In some cases the error bars are smaller than the symbol). Representative AFM 
images of GW4869-treated RBC after 15 h Pb(II) exposure in the absence of lysis (C,D). For experiments in A, 
SM was quantified using TLC39. For the experiments in B, FACS was used.
www.nature.com/scientificreports/
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Partial cholesterol removal accelerates morphological change. RBC membranes contain a 
high amount of cholesterol (~45 mol% lipid, in accordance with Owen, et al.25). Moreover, data from this and 
other laboratories suggest that a direct cholesterol-ceramide interaction may be taking place at high concen-
trations of both lipids27,28. Thus an experiment was designed to vary substantially the amount of cholesterol 
in RBC membranes but without causing major morphological effects per se. Treating the cells with 0.25 mM 
β-methylcyclodextrin (βMCD) under the conditions described in the Methods section RBC cholesterol (Chol) 
contents decreases by 31.5 ± 3.5% (n = 3) in agreement with data in the literature41. βMCD treatment preserves 
the typical doughnut morphology (Fig. 7A), except that the thickness at the rim (‘maximum thickness’) is higher 
in the βMCD-treated cells (2.1 vs. 1.4 µm, Table 2). The thickness and diameter data suggest that the mode of 
adhesion of the βMCD-treated cells is different so that they become less flattened in the process. When 10 µM 
Pb2+ is added the time-course of events is somehow faster, so that spherocytes are predominant after 40 min 
(Fig. 7B), as compared with 1 h for intact RBC. Pb2+ causes a similar decrease in diameter (21%) as in the native 
RBC, but the average increase in thickness is only 44%, from 2.1 to 3.1 µm (Table 2). The shorter times required in 
βMCD-treated cells after Pb2+ addition for spherocyte formation may be caused by a higher free Cer concentra-
tion due to lower cholesterol levels. A possible explanation for this result is that, perhaps, under these conditions 
ceramide-rich domains would be more easily formed. Another possibility is that hypothetical complex gel-like 
phases enriched in both ceramide and cholesterol become more Cer-enriched, as their properties are modulated 
by Cer: Chol ratio. This would be in agreement with the results observed in RBC lipid extract experiments29, as 
RBC lipid extracts in the presence of Cer show Cer-enriched domains which, after Chol depletion, stiffen signif-
icantly. Chol – Cer interactions have been further described in a recent review42.
Fluorescence microscopy studies. Confocal fluorescence microscopy studies were carried out with the 
aim of detecting and localizing ceramide and externalized PS. The former was labeled with an antiCer specific 
antibody (ALX-804–196 as primary, Alexa Fluor 633 as secondary), while the latter was identified through the 
ability of PS to bind Annexin V. Ceramide (pseudocolour red) appears in Fig. 8 as localized dots, whose number 
increases for 20 min after Pb2+ addition, in agreement with the FACS data (Fig. 4B). Ceramide is known to give 
rise to rigid microdomains as soon as it is formed by hydrolysis of SMase24,43,44. ALX-804–196 specificity against 
ceramide has been questioned45. However in our hands the antibody binds Cer with much higher affinity than 
phosphatidylcholine (Supplementary Fig. 2).
Annexin V (pseudocolour green) indicates the presence of PS in the RBC plasma membrane outer monolayer. 
Figure 9A–C show the expected external location of annexin V in Pb2+ -treated RBC after 20 min. This is par-
ticularly clear in Fig. 9B, which shows as well the presence of single “poles” enriched in annexin V in the cells. 
The meaning of these hot spots of scramblase activity is not clear at present. Figure 9D includes a quantitation 
of externalized PS using FACS. An overlay of the ceramide and annexin V signals 20 min after Pb2+ addition is 
Inhibitor Inhibition Efficiency (%)
None 0
GW4869 (15 µM) 59.9 ± 1.1
GSH (5 mM) 92.0 ± 8.7
CLT (10 µM) 76.3 ± 4.5
Table 3. Inhibition of Pb(II)-induced hemolyisis. Average values ± S.E.M. (n = 3). Data obtained as detailed 
under Methods.
Figure 7. Pb2+ effect on βMCD-treated RBC. RBCs were incubated with 0.25 mM βMCD for 30 minutes at 
37 °C for partial cholesterol depletion. AFM imaging of βMCD-treated RBCs reveals that they preserve their 
typical doughnut morphology (A). When Pb2+ is applied to them at 37 °C, spherocytes can be detected after 
40 minutes (B), while without βMCD they took longer (>1 hour, Fig. 3E).
www.nature.com/scientificreports/
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shown in Fig. 9E. Not all cells displaying extensive annexin V binding contain also ceramide dots. This can be due 
to the lack of three-dimensional imaging in these samples.
Discussion
Phospholipid scramblases (PLSCRs) are a group of single-pass plasma membrane proteins that would carry out 
Ca2+ -dependent, non-specific and bidirectional movement (scrambling) of phospholipids46,47. This randomiza-
tion of plasma membrane phospholipids leads to the surface exposure of PS that is an essential requirement for 
phagocytosis, blood coagulation and activation of anti-inflammatory responses in eukaryotic cells48–51. In par-
ticular, PS translocation from the inner to the outer leaflet of the plasma membrane is critical for recognition and 
clearance of apoptotic cells by macrophages52,53.
The role of PLSCR in apoptosis remains unclear given the presence of additional enzymes associated with 
plasma membrane phospholipid translocation such as aminophospholipid translocase32,54–56. Moreover, PLSCR1 
appears to play important roles at the nuclear level, apparently unrelated to membrane lipid motions57,58. PLSCR 
family members contain a conserved calcium-binding motif, and Zhou, et al.59 found that mutation of residues in 
Figure 8. Confocal microscopy monitorization of ceramide generation over time during Pb2+ incubation. 
Exposure times: 0 min (A), 8 min (B), 10 min (C), 20 min (D,E). Images are a combination of transmitted 
light and fluorescence confocal microscopy, where red dots indicate ceramide-enriched zones detected by the 
antiCer- antibody (Alexa Fluor 633 as secondary antibody).
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this region of PLSCR1 completely removed enzymatic activity. PLSCR1 is phosphorylated at Thr-161 by PKC-δ, 
which translocates to the plasma membrane during apoptosis34.
Our results show that Pb2+ increases intracellular Ca2+ (Fig. 1B,C,D). This is in agreement with the obser-
vations by Kempe, et al.7. These authors attributed the increased cytosolic Ca2+ concentration to either a Pb2+ 
-induced cell shrinkage, activation of an undetected Ca2+ -channel, or inhibition of Ca2+ -ATPase. The latter 
enzyme is known to be inhibited by Pb2+ 60–62. Earlier work shows that the cytoplasmic Ca2+ concentration and 
induction of apoptosis are directly related to each other48–50. A change in conformation of PLSCR1 upon Ca2+ 
binding has been proposed by Stout, et al.63. Other results64 show that the ionic interaction of Ca2+ with PLSCR1 
peptides lead to a change in conformation of the protein around the Ca2+ binding motifs. However, free cytosolic 
Ca2+ may also act as a second messenger and activate many cytosolic proteins involved in apoptotic pathways64. 
Lang’s group7 has demonstrated that [Pb2+] > 0.1 µM also activates erythrocyte K+ channels, leading to eryth-
rocyte shrinkage, and to activation of the erythrocyte scramblase, causing PS exposure. Pb2+ ions have been 
demonstrated to directly activate Ca2+ -sensitive Gardos K+ -channels (BK channels) in human erythrocytes65 
and similar Ca2+ -sensitive K+ -channels in other cell types66,67. However, the fact that we have found that Pb2+ 
induced Ca2+ entry and PS exposure in CHO cells only when the latter had been transfected with PLSCR1 gene 
Figure 9. Confocal microscopy visualization of PS exposure after 20 min Pb2+ incubation. Annexin V was used 
to detect PS translocation and detected by fluorescence (green). Transmitted light (A), fluorescence (B) and mix 
of both images (C). Percentage of cells that expose PS using FACS (three different experiments, 10000 cells per 
experiment) (D). RBC treated with both annexin V and antiCer (Alexa Fluor 633 as secondary antibody) (E). 
Images in C and E are a combination of transmitted light and fluorescence confocal microscopy, where red dots 
indicate ceramide-enriched zones detected by the antiCer antibody as in Fig. 8.
www.nature.com/scientificreports/
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(Figs 1 and 2, and Table 1) is a direct demonstration that scramblase is involved in Pb2+.-induced PS flopping. In 
addition, alternative Ca2+ -independent mechanisms of PLSCR1 activation have been suggested under certain 
conditions68.
Clotrimazole is an inhibitor of BK channels. It has been found to inhibit Pb2+ -induced PS flip-flop motion 
and annexin V binding (Fig. 1E). The inhibition is largely due to a channel blockade69. BK channels open up 
when the intracellular Ca2+ concentration increases, and allow the efflux of intracellular K+ to the extracellu-
lar medium70. Clotrimazole also inhibits the Pb2+ -induced morphological changes in the RBC, which suggests 
a role for the perturbation of ionic concentration in the shape changes. Dreher, et al.71 reported that modest 
increases in intracellular Ca2+ concentrations caused the appearance of pathologic changes in erythrocyte shape 
and deformability. However these changes were prevented when the cells were suspended in high-K+ buffers, 
suggesting a role for K+ in the shape changes. Glaser, et al.72 and Bifano, et al.73 have also related shape changes 
to membrane potential in RBC, thus to K+ concentrations and fluxes. Bifano, et al.73 observed that increased 
intracellular Ca2+ enhanced K+ conductance and cell membrane hyperpolarization. Under these circumstances 
these authors observed echinocytosis, just as in our case (Fig. 3B–D). Clotrimazole blocks the K+ channels and 
no echinocytosis is observed (Fig. 3F,G).
Echinocytosis is very likely to elicit the SMase activity described by López, et al.39, as any other membrane 
bending process, thus a cause-effect relationship is observed between Pb2+, increase in intracellular Ca2+ 7, K+ 
outflow71, echinocytosis73, and SMase activation39. SMase activity is found in our cells under conditions caus-
ing echinocytosis (Fig. 6A). The generation of ceramide could explain the reported increase in the order of the 
membranes by the effect of Pb2+ 16, which could act through membrane platforms (Fig. 8). SMase inhibition by 
GW4869 does not inhibit echinocytosis (Fig. 5C) but CLT does inhibit spike formation, and CLT inhibits both 
echinocytosis and SMase activity (Figs 3F and 6B). This supports the flow of information summarized in Fig. 10. 
Cholesterol depletion accelerates the morphological change and this could be related to ceramide-enriched plat-
forms, as less cholesterol promotes their generation and could stiffen the domains. However, recent reports indi-
cate that scramblase 1 could also interact with cholesterol74, and the possibility of cholesterol depletion enhancing 
scramblase activity cannot be discarded.
The last step in this series of events would be the PS exposure to the outer membrane as a result of flip-flop 
phospholipid motion. As far as we know, flip-flop can occur either as a result of SMase-dependent ceramide 
formation17,18, or through the action of a scramblase, or both. Human scramblase 1 has been shown to catalyze 
phospholipid flip-flop in the absence of ceramide15,47,75,76. In our hands, SMase inhibition by GW4869 partially 
inhibits PS externalization (Fig. 9D), while inhibition of Ca2+ entry, essential for scramblase activation, by clo-
trimazole abolishes all downstream changes. These data suggest that scramblase and ceramide act jointly towards 
the membrane lipid scramblase effect, and subsequent externalization of PS.
Our results also support the idea, proposed by Kempe, et al.7, that scramblase activation is at the origin 
of the observed anemia after Pb2+ intoxication. Recent findings suggest that PS exposure also occurs under 
Figure 10. Pb2+ -induced changes on RBC. General outline of the process.
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non-apoptotic conditions. Many pathological conditions cause surface exposure of PS, suggesting activation 
of PLSCRs77. Cytosolic Ca2+ is known to increase in several conditions (e.g. thalassemia, sickle cell disease, 
glucose-6-phosphate dehydrogenase deficiency) where scramblases need to be activated and the rate of apoptosis 
is increased78,79. In the light of the above results, lead could be an aggravating factor in those diseases.
In conclusion, in the present work we show evidence of the effects of Pb2+ ions on red blood cells, and we 
characterize the mechanism of this eryptotic process. Pb2+ causes Ca2+ entry which in turn causes K+ depletion 
from the cell. This process can be stopped at this point using clotrimazole. After K+ depletion, the red blood cells 
undergo a morphological change that initially flattens the cell and leads to the generation of spikes (echinocyto-
sis), and finally to spherocytes. Ceramide generation is linked to the morphological change and the process can 
be stopped at this point using GW4869 neutral sphingomyelinase inhibitor. Finally, the cell activates a scram-
blase and ‘flip-flop’ lipid motion occurs, exposing PS from the inner leaflet of the cell membrane to the outer 
monolayer, and leading to hemolysis. This work is relevant in the context of cell death, heavy metal toxicity and 
sphingolipid signaling.
Materials and Methods
Materials. Lead acetate, Fura-2AM, EMEM (Essential Minimum Eagle Medium), BSA (bovine serum albu-
min), Clotrimazole and GW4869 were obtained from Sigma (St Louis, MO, USA). Annexin V-fluorescein isothi-
ocyanate conjugate (FITC) Kit was purchased from Molecular Probes (Eugene, OR, USA). Alexa Fluor 633 goat 
anti-mouse IgM, Lipofectamine 2000 and pc DNA 3.1 were from Invitrogen (Carlsbad, CA, USA). 1-oleoyl-2-[6-
[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phosphoserine (C6-NBD-PS) was obtained 
from Avanti Polar Lipids Alabaster, AL. ALX-804-196 Ceramide, mAb (MID 15B4) (“antiCer” antibody) was 
purchased from Enzo Life Sciences, Inc. (Farmingdale, NY, USA). All other reagents and solvents for assay were 
of analytical reagent grade and were purchased from Sigma-Aldrich.
Isolation of RBC. Whole blood was obtained from informed healthy volunteers by venipuncture. RBC were 
collected by centrifugation (1700 g, 10 min) and resuspended in RBC buffer (32 mM HEPES, 125 mM NaCl, 1 mM 
MgSO4, 1 mM CaCl2, 5 mM KCl, 5 mM glucose, pH 7.2). The process was repeated two more times to increase 
efficiency. The haematocrit level was adjusted to 1% (A412 ≈ 0.6 for a 25 µl -on- 1 ml distilled water dilution).
Labeling of RBC with C6-NBD phospholipids. Washed human RBC were resuspended in RBC buffer to 
a cell concentration of 5.108 cells/mL and loaded with 2 µM C6-NBD-PS. Translocation of the probe proceeded 
for 1 h at 37 °C, resulting in 75–95% internalization. To measure outward movement, residual C6-NBD-lipid 
remaining in the cells outer monolayer was removed by washing for 5 min with ice-cold 0.5% BSA prior to the 
experiment.
Translocation of RBC membrane lipids from the inner to the outer leaflet. Outward movement 
of C6-NBD-PS was measured using the BSA back-exchange procedure as described by Connor, et al.80. Labelled 
RBC were incubated with different Pb2+ concentrations at 37 °C. Briefly, 200 µL aliquots from the cell suspen-
sion were removed at the indicated time intervals and placed on ice for 5 min in the presence or absence of 1% 
BSA. Pellets obtained after 3 min centrifugation at 12000 g were solubilized in 2 mL 1% (w/v) Triton X-100, and 
the amount of externalised probe was determined by comparing the fluorescence intensity associated with the 
cells before and after back-exchange. The amount of probe extracted into BSA was related to the control sample 
incubated without Pb2+, that was established as 100%. The fluorescence assay was measured at 37 °C, using an 
SLM Aminco 8100 spectrofluorometer, equipped with a circulating water bath. The excitation and emission wave-
lengths were 480 and 525 nm respectively.
Hemolysis assay. The hemolysis assay was performed in 1-ml test tubes by mixing the erythrocyte suspen-
sion (A412 ≈ 0.6) with the required lead concentrations. Inhibitors were applied previously in the corresponding 
samples and preincubated for 1 hour. The mixtures were incubated at 37 °C for 1 h in the presence of Pb(II) with 
gentle shaking. After centrifugation at 1700 g for 5 min, hemolytic activity was measured as the increase in A412 
(i.e., increase in hemoglobin content) of the supernatant (Equations 1 and 2). Inhibition efficiency was calculated 
following Equation 3.
= ·lysis
A
A
% 100
(1)
supernatant
resuspended
412,
412,
Δ = −lysis lysis lysis% % % (2)sample control
=
Δ − Δ
Δ
⋅+Inhibition Efficiency
lysis lysis
lysis
(%)
% %
%
100
(3)
Pb Pb inh
Pb
Δ%lysisPb stands for the increase in cell lysis for the Pb-containing sample without inhibitor, and Δ%lysisPb+inh 
stands for the increase in cell lysis for the Pb + inhibitor sample. Complete inhibition of the process 
(Δ%lysisPb+inh = 0) would render a 100% inhibition efficiency, while the opposite case, a lack of effect of the 
inhibitor (Δ%lysisPb+inh = Δ%lysisPb), would render a 0% inhibition efficiency.
Measurement of cell [Ca2+]i. Cells were loaded with 4 µM Fura2-AM at 37 °C for 30 min. Excess Fura2-AM 
was removed by rinsing twice with buffer. Both the cells undergoing Pb2+ treatment and the control group were 
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resuspended in buffer. Fluorescence intensity was monitored at an emission wavelength of 510 nm, by using a pair 
of excitation wavelengths at 340 nm and 380 nm, and subsequently expressed as the ratio of light excited at 340 nm 
to that at 380 (FR). Cells were permeabilized with 0.03% Triton X-100 and Fmax was obtained. EGTA (3 mM final 
concentration) was then added and Fmin was obtained. Sf2/Sb2 is the ratio between the excitation efficiencies of 
free probe and Ca2+ -bound probe at 380 nm. [Ca2+]i was calculated according to the equation of Grynkiewicz, 
et al.81 (Equation 4).
=
−
−
+[Ca ] Kd (F F )
(F F )
Sf
Sb (4)
2
i
R min
max R
2
2
Where Kd is 371 ± 71 nM.
Cell culture. Chinese hamster ovary CHO-K1 cells were obtained from the American Type Culture 
Collection. These cells were maintained in EMEM containing 10% foetal bovine serum and 5000 U/ml penicillin 
and streptomycin under a humidified atmosphere of 5% CO2 in air.
Transfection of CHO cells. CHO-K1 cells, grown to 70–80% confluence, were transfected with 
pcDNA-PLSCR1 or pcDNA-3/1 (the latter lacking the scramblase gene) using LIPOFECTAMINETM 2000 rea-
gent according to the manufacturer’s instructions. Transfected cells were grown for 24 h before analysis. 5 h after 
transfection cells were switched to growth medium containing 350 µg/ml Geneticin antibiotic (G418) and the 
selection medium was refreshed every 24 h.
Mass spectrometric analysis of RBC sphingolipids. Lipid extraction was performed using a modi-
fied MTBE protocol (see Guri, et al.82). Briefly RBC were transferred into a 2 mL Eppendorf tube. Then, 360 μl 
methanol was added and vortexed. A mixture of lipid standards (see Table 4) was added and the cells were vor-
texed for 10 min at 4 °C using a Cell Disruptor Genie (Scientific Industries, Inc., Bohemia, NY). MTBE (1.2 mL) 
was then added and the samples were incubated for 1 h at room temperature with shaking (750 rpm). Phase 
separation was induced by adding 200 μl H2O. After 10 min incubation at room temperature, the sample was 
centrifuged at 1000 × g for 10 min. The upper (organic) phase was transferred to a 13 mm screw-cap glass tube 
and the lower phase was extracted with 400 μl artificial upper phase (MTBE/methanol/water (10:3:1.5, v/v/v)). 
The two upper phases were combined and the total lipid extract (in a 13 mm glass tube) was dried in a Centrivap 
at 50 °C or under a nitrogen flow. The aliquot was deacylated to eliminate phospholipids by methylamine treat-
ment (Clarke method). 0.5 mL monomethylamine reagent (MeOH/H2O/n-butanol/Methylamine solution 
(4:3:1:5 v/v) was added to the dried lipid, followed by sonication (5 min). Samples were then mixed and incubated 
for 1 h at 53 °C and dried (as above). The monomethylamine-treated lipids were desalted by n-butanol extraction. 
300 μl H2O-saturated n-butanol was added to the dried lipids. The sample was vortexed, sonicated for 5 min and 
150 μl MS-grade water was added. The mixture was vortexed thoroughly and centrifuged at 3200 × g for 10 min. 
The upper phase was transferred to a 2 mL amber vial. The lower phase was extracted twice more with 300 μl 
H2O-saturated n-butanol and the upper phases were combined and dried (as above).
Sphingolipids were detected on a Triple Quadrupole TSQ Vantage mass spectrometer (Thermo Fischer 
Scientific, Waltham, MA). Sphingolipid aliquots were resuspended in 250 μl chloroform/methanol (1:1 v/v) 
(LC-MS/HPLC grade) and sonicated for 5 min. The samples were pipetted into a 96-well plate (final vol-
ume = 100 μl). The samples were diluted 1:10 in positive mode solvent (Chloroform/Methanol/Water 
(2:7:1 v/v) + 5 mM ammonium acetate) and infused into the mass spectrometer. Tandem mass spectrometry for 
the identification and quantification of sphingolipid molecular species was performed using Multiple Reaction 
Monitoring (MRM) with a TSQ Vantage Triple Stage Quadrupole Mass Spectrometer (Thermo Fisher Scientific) 
equipped with a robotic nanoflow ion source, Nanomate HD (Advion Biosciences, Ithaca, NY). The collision 
energy was optimized for each lipid class. The detection conditions for each lipid class are listed below (Table 4). 
Ceramide species were also quantified with a loss of water in the first quadrupole. Each biological replicate was 
read in 2 technical replicates (TR). Each TR comprised 3 measurements for each transition. Lipid concentrations 
were calculated relative to the relevant internal standards and then normalized to the total lipid content of each 
lipid extract (mol%).
Assays for PS externalization and ceramide domain visualization. Cells grown on glass covers-
lips were rinsed with PBS and incubated with different concentrations of Pb2+. Annexin-V-FITC staining was 
performed according to the manufacturer’s instructions. After rinsing coverslips with binding buffer to remove 
unbound annexin-V, cells were fixed with 3% paraformaldehyde for 15 min and rinsed twice with PBS. As for 
ceramide domain visualization, cells were incubated with antiCer, centrifuged at 1700 g for 10 min to remove 
Lipid Class Standard Polarity Mode m/z ion Collision Energy (eV)
Ceramide C17Cer + Product ion 264.34 25
Dihydroceramide C17Cer + Product ion 266.34 25
Hexosylceramide C8GC + Product ion 264.4 30
Hexosyldihydroceramide C8GC + Product ion 266.4 30
Sphingomyelin C12SM + Product ion 184.07 26
Table 4. Standards and conditions for mass spectrometric analysis of RBC sphingolipids.
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supernatant (cells were resuspended with RBC buffer) and reincubated with Alexa Fluor 633 followed by an 
additional centrifugation step. Cells were resuspended with RBC buffer, then fixed with 3% paraformaldehyde. 
Coverslips were mounted on glass slides. Confocal images were acquired with an Olympus Fluoview FV500 
confocal microscope.
Fluorescence-activated cell sorting analysis. Fluorescence-activated cell sorting (FACS) anal-
ysis was performed as described previously83. After incubation in the presence or absence of Pb2+ cells were 
stained with Annexin-V-FITC and fluorescence was measured using flow cytometric analysis (FACS Calibur; 
Becton-Dickinson, Franklin Lakes, NJ). For each sample, the fluorescence from 10,000 events was acquired for 
data analysis and the results were expressed as the mean fluorescence intensity of cells, selected in a forward- 
versus side-scatter window. Annexin fluorescence intensity was measured in fluorescence channel FL-1 with 
λex = 488 nm and λem = 530 nm, while for ceramide detection λex = 625 nm and λem = 660 nm was used. All meas-
urements were performed in triplicate. These experiments were performed in the Flow Cytometry Service of the 
University of the Basque Country (UPV/EHU).
RBC preparation for atomic force microscopy (AFM) imaging. Red blood cell suspension was pre-
pared by 80-fold dilution of the 1% haematocrit-adjusted suspension in RBC buffer. This diluted suspension was 
set on an ethanol-washed round glass coverslip and left for 10–15 minutes for adhesion. To both facilitate AFM 
imaging and stop the Pb(II)-induced cell death process, 0.5% glutaraldehyde was added after the adhesion time.
AFM imaging. Experiments were carried out at room temperature (23 °C) in a JPK Nanowizard II AFM (JPK 
Instruments, Berlin, Germany). Images were captured at 1 Hz with 512 × 512 pixels. For this purpose, V-shaped 
MLCT silicon nitride cantilevers were used (Bruker AXS, Karlsruhe, Germany) in contact mode, with enough 
force to reduce the overestimation of cell diameters at the edges without compromising cell integrity. Images were 
collected at 512 × 512-pixel resolution at a scanning rate of 1 Hz and line-fitted using the JPK Data Processing 
software as required. Cell diameters were measured on the images along the Y and X axis for each cell, combin-
ing both data (as RBC have almost circular shape when attached to support). Cell thickness was measured by 
cross-section analysis of the RBC images.
Cholesterol partial depletion. β-methylcyclodextrin (βMCD) was prepared in RBC buffer to a 0.25 mM 
final concentration. RBC were incubated in this βMCD-containing buffer at 37 °C for 30 minutes to achieve par-
tial cholesterol removal40. Then RBC were washed by centrifugation (1700 g, 10 min) discarding the supernatant 
and resuspended in βMCD-free RBC buffer. Cholesterol quantification was performed with the cholesterol oxi-
dase/peroxidase Automated Systems Reagent (BioSystems, Barcelona, Spain) kit.
Ethical Aspects. All methods were carried out in accordance with relevant guidelines and regulations. 
Informed consent was obtained from all subjects (blood donors). This study was approved by the Research Ethics 
Committee from the University of the Basque Country (Comité de Ética en la Investigación y la Práctica Docente 
de la Universidad del País Vasco/Euskal Herriko Unibertsitatea, CEID/IIEB)
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